Structures by: Gunawardana C. A.
Total: 20
CG-P2-L1-EtOAc N-(2-pyridylmethyl)-2,2-biimidazole
C12H11N5
Faraday Discuss. (2017)
a=21.5686(12)Å b=5.8077(3)Å c=18.0356(10)Å
α=90.00° β=110.1298(16)° γ=90.00°
CG-P2-A3-D7 [N-(4-pyridylmethyl)-2,2-biimidazole]2, 1,2-diiodotetrafluorobenzene
(C12H11N5)2(C6F4I2)
Faraday Discuss. (2017)
a=17.386(2)Å b=19.378(3)Å c=19.435(3)Å
α=92.996(5)° β=106.710(5)° γ=106.560(4)°
C18H21N5O4
C18H21N5O4
Faraday Discuss. (2017)
a=17.295(2)Å b=4.8014(7)Å c=21.977(3)Å
α=90° β=90.912(11)° γ=90°
C12H11N5
C12H11N5
Faraday Discuss. (2017)
a=5.493(2)Å b=10.339(4)Å c=10.611(4)Å
α=112.83(2)° β=99.24(3)° γ=94.16(3)°
C12H11N5,C7H6O2
C12H11N5,C7H6O2
Faraday Discuss. (2017)
a=6.42690(10)Å b=9.9656(2)Å c=13.5194(3)Å
α=96.6910(10)° β=95.6860(10)° γ=100.6030(10)°
C12H11N5,0.5(C6F4I2)
C12H11N5,0.5(C6F4I2)
Faraday Discuss. (2017)
a=5.0691(14)Å b=8.055(2)Å c=19.750(5)Å
α=93.952(13)° β=93.442(12)° γ=105.938(16)°
C12H12N5,C8H13O4
C12H12N5,C8H13O4
Faraday Discuss. (2017)
a=5.1948(2)Å b=10.8967(3)Å c=18.2317(6)Å
α=105.5790(10)° β=95.6070(10)° γ=100.1040(10)°
CG-P2-A2-D10 N-(3-pyridylmethyl)-2,2-biimidazole, 1,3,5-F3-2,4,6-I3-benzene
(C12H11N5)(C6F3I3)
Faraday Discuss. (2017)
a=16.0707(15)Å b=9.0666(8)Å c=14.8610(14)Å
α=90.00° β=107.218(3)° γ=90.00°
C12H11N5,C7H6O2
C12H11N5,C7H6O2
Faraday Discuss. (2017)
a=7.028(2)Å b=9.024(3)Å c=13.602(4)Å
α=90.229(19)° β=91.564(17)° γ=93.223(16)°
C12H11N5
C12H11N5
Faraday Discuss. (2017)
a=7.490(3)Å b=9.841(4)Å c=15.253(5)Å
α=90° β=99.072(17)° γ=90°
C12H11N5,0.5(C12H22O4)
C12H11N5,0.5(C12H22O4)
Faraday Discuss. (2017)
a=5.2936(3)Å b=7.9437(5)Å c=22.8847(13)Å
α=81.583(5)° β=85.500(6)° γ=70.615(5)°
CG-P2-A2-HBD2 [N-(3-pyridylmethyl)-2,2-biimidazole]2, HOOC-(CH2)8-COOH
(C12H11N5)2(C10H18O4)
Faraday Discuss. (2017)
a=5.7402(10)Å b=9.3514(16)Å c=14.973(3)Å
α=97.467(5)° β=91.771(6)° γ=97.861(5)°
CG-P2-A3-HBD1 N-(4-pyridylmethyl)-2,2-biimidazole, HOOC-(CH2)2-COOH
(C12H11N5)(C4H6O4)
Faraday Discuss. (2017)
a=4.8081(7)Å b=11.0210(17)Å c=14.819(2)Å
α=97.881(6)° β=91.543(6)° γ=90.181(6)°
CG-P2-A3-D9 [N-(4-pyridylmethyl)-2,2-biimidazole]2, 1,4-diiodotetrafluorobenzene
(C12H11N5)2(C6F4I2)(C1H4O)
Faraday Discuss. (2017)
a=13.4945(9)Å b=14.8017(10)Å c=19.3714(13)Å
α=111.285(2)° β=92.518(2)° γ=112.668(2)°
C33H16I4,C24H20P,Br
C33H16I4,C24H20P,Br
Chemical communications (Cambridge, England) (2018) 54, 6 607-610
a=17.4076(9)Å b=17.4445(11)Å c=34.0495(19)Å
α=90° β=90.184(4)° γ=90°
C33H16I4,C24H20P,I
C33H16I4,C24H20P,I
Chemical communications (Cambridge, England) (2018) 54, 6 607-610
a=17.4190(11)Å b=17.3989(8)Å c=34.9081(17)Å
α=90° β=90.638(6)° γ=90°
C33H16I4,C24H20P,Cl
C33H16I4,C24H20P,Cl
Chemical communications (Cambridge, England) (2018) 54, 6 607-610
a=17.3730(6)Å b=17.4497(7)Å c=33.5122(11)Å
α=90° β=90.168(4)° γ=90°
CG-P1-A1-HBD1 N-(2-pyridylmethyl)-2,2-biimidazole, HOOC-(CH2)2-COOH
(C12H11N5)(C4H6O4)
Faraday Discuss. (2017)
a=5.0716(9)Å b=11.314(2)Å c=14.051(3)Å
α=90.818(7)° β=99.190(6)° γ=99.925(6)°
CG-P2-A2-HBD2 [N-(3-pyridylmethyl)-2,2-biimidazole]2, HOOC-(CH2)4-COOH
(C12H11N5)2(C6H10O4)
Faraday Discuss. (2017)
a=8.0078(17)Å b=10.167(2)Å c=18.969(4)Å
α=79.276(6)° β=82.529(5)° γ=70.640(5)°
C12H11N5,0.5(C6F4I2)
C12H11N5,0.5(C6F4I2)
Faraday Discuss. (2017)
a=5.4649(17)Å b=11.660(4)Å c=12.493(4)Å
α=84.163(17)° β=80.913(13)° γ=76.728(13)°